Pharmacologic management of hypertension in patients with diabetes

  • Whalen K
  • Stewart R
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Hypertension is a common comorbidity in patients with diabetes, and adequate control of blood pressure significantly reduces the risk of macrovascular and microvascular complications. Patients with diabetes should achieve a target blood pressure of less than 130/80 mm Hg. The use of angiotensin-converting enzyme inhibitors may slow progression to kidney failure and cardiovascular mortality; these agents are the preferred therapy for managing coexisting diabetes and hypertension. Angiotensin receptor blockers can prevent progression of diabetic kidney disease and are a first-line alternative for patients intolerant of angiotensin-converting enzyme inhibitors. Thiazide diuretics provide additional antihypertensive effects when combined with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. With lower doses of these drugs, the risk of clinically significant metabolic alterations is minimal. Beta blockers and calcium channel blockers also have beneficial effects in managing hypertension in patients with diabetes. Beta blockers reduce cardiovascular events and are useful in a multidrug regimen. Dihydropyridine calcium channel blockers should be reserved for patients intolerant of preferred agents or those who need additional therapy to achieve target blood pressure. Many patients with diabetes require combination therapy with multiple antihypertensive agents. Copyright (copyright) 2008 American Academy of Family Physicians.

Author-supplied keywords

  • alcohol consumption
  • altace
  • amlodipine
  • amlodipine besylate
  • angiotensin receptor antagonist
  • antihypertensive therapy
  • atenolol
  • avapro
  • blood pressure regulation
  • calan
  • capoten
  • captopril
  • carvedilol
  • chlortalidone
  • comorbidity
  • coreg
  • cozaar
  • diabetes mellitus
  • diabetic patient
  • diet
  • dihydropyridine
  • dipeptidyl carboxypeptidase inhibitor
  • disease course
  • drug dose regimen
  • drug dose titration
  • drug megadose
  • drug tolerability
  • enalapril
  • enalapril maleate
  • exercise
  • glucose intolerance
  • human
  • hydralazine
  • hydrochlorothiazide
  • hypertension
  • insulin sensitivity
  • irbesartan
  • isoptin
  • kidney failure
  • lifestyle modification
  • lisinopril
  • losartan
  • losartan potassium
  • low drug dose
  • micardis
  • mortality
  • nitrendipine
  • norvasc
  • placebo
  • prinivil
  • ramipril
  • review
  • risk reduction
  • side effect
  • smoking cessation
  • sodium restriction
  • systolic blood pressure
  • telmisartan
  • tenormin
  • thalitone
  • vasotec
  • verapamil
  • weight reduction

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • K L Whalen

  • R D Stewart

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free